TAF12 Antibody

What is TAF12 and what is its biological function?

TAF12, also named TAF15 or TAF2J, is a TBP-associated factor that functions as a component of the transcription factor IID (TFIID) complex. This complex is essential for mediating regulation of RNA polymerase II transcription. TAF12 plays a key role in regulating eukaryotic gene expression by directly binding promoters and enhancer-bound transactivator proteins .

The TFIID basal transcription factor complex recognizes and binds promoters with or without a TATA box via its subunit TBP (TATA-box-binding protein) and promotes assembly of the pre-initiation complex (PIC) . TAF12 is also a component of other protein complexes including the TATA-binding protein-free TAF complex (TFTC), the PCAF histone acetylase complex, and the STAGA transcription coactivator-HAT complex .

What are the molecular characteristics of the TAF12 protein?

TAF12 has the following molecular characteristics:

The difference between calculated and observed molecular weights may be attributed to post-translational modifications affecting protein migration in SDS-PAGE gels.

Which experimental applications are TAF12 antibodies validated for?

TAF12 antibodies have been validated for multiple experimental applications, with specific recommendations for each technique:

These antibodies have been successfully tested on human and mouse samples , with reactivity confirmed in multiple human cell lines including HEK-293T, A431, HepG2, and HeLa.

How can I validate TAF12 antibody specificity in my experimental system?

Thorough validation of TAF12 antibodies is essential for generating reliable research data. A comprehensive validation approach should include:

• Western Blot Validation:

  • Examine protein detection at the expected molecular weight (18-21 kDa)

  • Test multiple relevant cell lines (e.g., HEK-293T, HeLa) to confirm consistent detection

  • Include appropriate positive controls where TAF12 expression is established

• Knockdown/Knockout Validation:

  • Employ siRNA, shRNA, or CRISPR/Cas9 to reduce or eliminate TAF12 expression

  • Confirm the corresponding reduction in antibody signal intensity

  • This approach has been documented in published TAF12 research

• Immunoprecipitation Specificity:

  • Perform immunoprecipitation followed by Western blot detection

  • Compare with control IgG immunoprecipitation to establish specificity

  • Validate by mass spectrometry if possible to confirm target identity

• Cross-reactivity Assessment:

  • Test antibody in systems where TAF12 is known to be absent

  • Evaluate cross-reactivity with other TAF family members

How does TAF12 function in the TFIID complex?

TAF12 is an integral component of the TFIID complex, which is essential for RNA polymerase II-dependent transcription. Anti-TAF12 antibodies can detect all intermediates from core-TFIID to holo-TFIID, making them valuable tools for studying TFIID assembly and function . In contrast, anti-TBP antibodies will only detect the presence of holo-TFIID .

The TFIID complex consists of TBP and multiple TAF proteins (TAF1-13), which collectively:

• Recognize and bind to core promoter elements

• Facilitate recruitment of RNA polymerase II

• Serve as coactivators that interact with transcriptional activators

• Contribute to promoter selectivity

TAF12 specifically contributes to this process through its histone-fold domain and interactions with other TFIID components. The stability of TFIID is influenced by the presence of TAF12, as demonstrated in studies examining complex assembly and integrity.

What methods are recommended for studying TAF12 in chromatin immunoprecipitation experiments?

For optimal results in ChIP experiments using TAF12 antibodies, researchers should implement the following methodological approaches:

• Experimental Design Considerations:

  • Use TAF12 antibodies specifically validated for ChIP applications

  • For TFIID assembly studies, leverage the ability of anti-TAF12 antibodies to detect all TFIID intermediates

  • Include appropriate positive controls targeting known TAF12 binding sites

• Protocol Optimization:

  • Adjust crosslinking conditions to effectively capture protein-DNA interactions

  • Optimize sonication parameters to generate 200-500 bp DNA fragments

  • Use stringent washing conditions to reduce background signal

• Control Selection:

  • Include IgG control immunoprecipitation for background assessment

  • Consider parallel ChIP with other TFIID components (e.g., TBP) for comparative analysis

  • For studies involving RAS signaling, ETS1 binding sites can serve as positive controls

• Data Interpretation:

  • Account for TAF12's presence in multiple complexes (TFIID, TFTC, PCAF, STAGA)

  • Consider cell type-specific variations in TAF12 function and genomic binding

  • Validate findings with complementary techniques (e.g., reporter assays)

How does TAF12 contribute to RAS-induced carcinogenesis?

Research has identified significant roles for TAF12 in RAS-mediated oncogenic pathways. TAF12 levels are up-regulated in cell lines with natural RAS mutations or those stably overexpressing mutated RAS isoforms. This up-regulation occurs via a mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-dependent pathway .

Mechanistic studies using electrophoretic mobility shift assays and chromatin immunoprecipitation have revealed that the ETS1 transcription factor interacts with an ETS-binding site on the TAF12 promoter, regulating TAF12 expression. Notably, this binding is enhanced in extracts from oncogenic RAS-transformed cells, indicating a direct role in RAS-mediated regulation of TAF12 expression .

Functional studies using small interfering RNA (siRNA) to reduce TAF12 levels demonstrated:

• Destabilization of the TFIID complex

• Enhanced E-cadherin mRNA and protein levels

• Reduced migration and adhesion properties of RAS-transformed cells with epithelial to mesenchymal transition

These findings establish TAF12 as an important factor in RAS-induced transformation of human colon cells and the epithelial-to-mesenchymal transition process, particularly in aspects related to increased cell motility.

How does TAF12 depletion affect cellular processes and gene expression?

TAF12 depletion through siRNA treatment produces significant cellular and molecular effects, particularly in the context of RAS-transformed cells:

• Effects on Transcriptional Complexes:

  • Destabilization of the TFIID complex

  • Potential alteration of other complexes containing TAF12 (TFTC, PCAF, STAGA)

• Impact on Gene Expression:

  • Specifically enhances E-cadherin mRNA and protein levels

  • E-cadherin is a critical epithelial marker whose expression is typically suppressed during EMT

• Cellular Phenotype Changes:

  • Reduced cell migration capabilities

  • Altered adhesion properties in cells undergoing epithelial-to-mesenchymal transition

  • Potential reversal of mesenchymal characteristics toward epithelial phenotype

These observations highlight TAF12's role beyond general transcription, suggesting it functions as a gene-specific regulator that influences key cellular processes related to cancer progression and metastasis.

What is known about the interaction between TAF12 and ETS1 protein?

Research has established a regulatory relationship between TAF12 and the ETS1 transcription factor. Through electrophoretic mobility shift assays and chromatin immunoprecipitation, it has been demonstrated that ETS1 protein binds to an ETS-binding site on the TAF12 promoter and regulates TAF12 expression .

This interaction is particularly significant in oncogenic signaling contexts:

• The binding of ETS1 to the TAF12 promoter is enhanced in extracts from RAS-transformed cells

• This enhanced binding suggests a pathway where RAS signaling increases TAF12 expression through ETS1

• The regulatory mechanism creates a link between oncogenic signaling and the transcriptional machinery

Understanding this interaction provides insight into how transcription factors like ETS1 can mediate the effects of oncogenic signaling pathways by regulating components of the core transcriptional apparatus, such as TAF12.

What role does TAF12 play in TFIID assembly across different cell types?

TAF12 plays important but potentially context-dependent roles in TFIID assembly and function across different cell types:

These findings suggest that while TAF12 is universally part of TFIID, its specific roles and importance in complex assembly and function may vary significantly across different cellular contexts and developmental stages.